Small fiber neuropathy (SFN) is a peripheral nerve condition affecting thin myelinated Aδ
and unmyelinated C-fibers, characterized by severe neuropathic pain and other sensory and …

Background and Objectives Immune-mediated small fiber neuropathy (SFN) is increasingly
recognized. Acute-onset SFN (AOSFN) remains poorly described. Herein, we report a series …

The immune system has a role in neuropathic pain which includes autoimmune
mechanisms (eg, autoantibodies). Clinical studies have identified a number of conditions …

Objective Small fiber neuropathy (SFN) is clinically and etiologically heterogeneous.
Although autoimmunity has been postulated to be pathophysiologically important in SFN …

Abstract Introduction/Aims Small fiber neuropathies (SFN) have been associated with two
autoantibodies, trisulfated heparin disaccharide (TS‐HDS) and fibroblast growth factor …

Objectives: Small fiber neuropathy (SFN) is a subtype of painful neuropathies defined by
dysfunction of the Aδ and unmyelinated C fibers. It presents with both neuropathic pain and …

Small-fiber neuropathy (SFN) has few significant laboratory findings and is difficult to
diagnose. In 70% of the cases, the cause of SFN is unknown. Among the cases with known …

Small fiber neuropathy (SFN) is a peripheral nervous system disease due to affection of A‐
delta or C‐fibers in a proximal, distal, or diffuse distribution. Selective SFN (without large …

Objective: This retrospective study aims to recognize distinctive clinical and paraclinical
features of SFN in patients from Saint Louis University between 2014–2016. Background …

Objective: Novel antibodies to trisulfated heparin disaccharide (TS-HDS) and fibroblast
growth factor receptor 3 (FGFR-3) have been recently described in otherwise cryptogenic …